BACKGROUND:Chlorhexidine skin cleansing might substantially reduce neonatal infection and mortality in developing countries. Few data exist on the impact of chlorhexidine cleansing on skin colonization of infants during the first day of life or on the absorption potential of chlorhexidineduring newborn skin cleansing. METHODS:Hospital-born newborns in Kathmandu, Nepal were randomly allocated to full-body skin cleansing with 0.25%, 0.50%, or 1.00% chlorhexidine solution. Skin swabs were collected from the axilla, inguinal, and peri-umbilical areas before cleansing (baseline), and at 2 and 24 hours after treatment. Skin flora was quantified and organisms identified. In a subsample, heel prick blood was collected 24 hours after the cleansing and percutaneous absorption of chlorhexidine was assessed. RESULTS: Among 286 enrolled newborns, no adverse effects on skin were reported and body temperature was minimally reduced (mean reduction, 0.33 degrees C). In all groups, positive skin culture rates were significantly reduced at 2 hours but generally not at 24 hours; greater reductions were observed with higher concentrations of chlorhexidine. Effect at 24 hours was highest in the 1.00% group (37% lower positive skin culture rate). For 15 of 75 infants with heel pricks, chlorhexidine was detected at trace concentrations (<8 ng/mL, n = 14; 25.8 ng/mL, n = 1). CONCLUSIONS:Chlorhexidine skin cleansing seemed safe and reduced skin flora in newborns in a dose-dependent manner 2 hours after treatment. Greater residual effect at the highest concentration (1%) might provide broader benefit and may simplify combined maternal and neonatal regimens by matching the concentration used for vaginal cleansing during labor.
RCT Entities:
BACKGROUND:Chlorhexidine skin cleansing might substantially reduce neonatal infection and mortality in developing countries. Few data exist on the impact of chlorhexidine cleansing on skin colonization of infants during the first day of life or on the absorption potential of chlorhexidine during newborn skin cleansing. METHODS: Hospital-born newborns in Kathmandu, Nepal were randomly allocated to full-body skin cleansing with 0.25%, 0.50%, or 1.00% chlorhexidine solution. Skin swabs were collected from the axilla, inguinal, and peri-umbilical areas before cleansing (baseline), and at 2 and 24 hours after treatment. Skin flora was quantified and organisms identified. In a subsample, heel prick blood was collected 24 hours after the cleansing and percutaneous absorption of chlorhexidine was assessed. RESULTS: Among 286 enrolled newborns, no adverse effects on skin were reported and body temperature was minimally reduced (mean reduction, 0.33 degrees C). In all groups, positive skin culture rates were significantly reduced at 2 hours but generally not at 24 hours; greater reductions were observed with higher concentrations of chlorhexidine. Effect at 24 hours was highest in the 1.00% group (37% lower positive skin culture rate). For 15 of 75 infants with heel pricks, chlorhexidine was detected at trace concentrations (<8 ng/mL, n = 14; 25.8 ng/mL, n = 1). CONCLUSIONS:Chlorhexidine skin cleansing seemed safe and reduced skin flora in newborns in a dose-dependent manner 2 hours after treatment. Greater residual effect at the highest concentration (1%) might provide broader benefit and may simplify combined maternal and neonatal regimens by matching the concentration used for vaginal cleansing during labor.
Authors: Gary L Darmstadt; Nadia Badrawi; Paul A Law; Saifuddin Ahmed; Moataza Bashir; Iman Iskander; Dalia Al Said; Amani El Kholy; Mohamed Hassan Husein; Asif Alam; Peter J Winch; Reginald Gipson; Muhammad Santosham Journal: Pediatr Infect Dis J Date: 2004-08 Impact factor: 2.129
Authors: Gary L Darmstadt; Samir K Saha; A S M Nawshad Uddin Ahmed; M A K Azad Chowdhury; Paul A Law; Saifuddin Ahmed; Muhammad Asif Alam; Robert E Black; Mathuram Santosham Journal: Lancet Date: 2005 Mar 19-25 Impact factor: 79.321
Authors: G L Darmstadt; M Mao-Qiang; E Chi; S K Saha; V A Ziboh; R E Black; M Santosham; P M Elias Journal: Acta Paediatr Date: 2002 Impact factor: 2.299
Authors: Pavani K Ram; Farzana Begum; Christina Crabtree-Ide; Mohammad Rofi Uddin; Anne M Weaver; Md Golam Dostogir Harun; Jelena V Allen; Swapna Kumar; Sharifa Nasreen; Stephen P Luby; Shams El Arifeen Journal: Am J Trop Med Hyg Date: 2020-11 Impact factor: 2.345
Authors: Luke C Mullany; Joanne Katz; Subarna K Khatry; Steven C Leclerq; Gary L Darmstadt; James M Tielsch Journal: Arch Pediatr Adolesc Med Date: 2010-01
Authors: A Summers; M O Visscher; S K Khatry; J B Sherchand; S C LeClerq; J Katz; J M Tielsch; L C Mullany Journal: J Perinatol Date: 2017-11-09 Impact factor: 2.521
Authors: Aamer Imdad; Resti Ma M Bautista; Kathlynne Anne A Senen; Ma Esterlita V Uy; Jacinto Blas Mantaring; Zulfiqar A Bhutta Journal: Cochrane Database Syst Rev Date: 2013-05-31